Our study demonstrated for the first time that LDH‐5, encoded by the LDHA gene, exerts better prognostic value than serum LDH in pancreatic cancer and may complement tissue LDHA levels in providing prognosis information for patients with unresectable pancreatic cancer, where obtaining tissue biopsy may be difficult. The gene discussed is LDHA; the disease is familial pancreatic carcinoma.